Integrating Network Pharmacology with in vitro Experiments to Validate the Efficacy of Celastrol Against Hepatocellular Carcinoma Through Ferroptosis

References

• Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet. 2018;391(10127):1301–1314. doi:10.1016/S0140-6736(18)30010-2
   PubMed Web of Science ®Google Scholar
• Llovet JM, Zucman-Rossi J, Pikarsky E, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2016;2:16018. doi:10.1038/nrdp.2016.18
   PubMed Web of Science ®Google Scholar
• Chen J, Li X, Ge C, Min J, Wang F. The multifaceted role of ferroptosis in liver disease. Cell Death Differ. 2022;29(3):467–480. doi:10.1038/s41418-022-00941-0
   PubMed Web of Science ®Google Scholar
• Yang M, Wu X, Hu J, et al. COMMD10 inhibits HIF1α/CP loop to enhance ferroptosis and radiosensitivity by disrupting Cu-Fe balance in hepatocellular carcinoma. J Hepatol. 2022;76(5):1138–1150. doi:10.1016/j.jhep.2022.01.009
   PubMed Web of Science ®Google Scholar
• Yao F, Deng Y, Zhao Y, et al. A targetable LIFR-NF-κB-LCN2 axis controls liver tumorigenesis and vulnerability to ferroptosis. Nat Commun. 2021;12(1):7333. doi:10.1038/s41467-021-27452-9
   PubMed Web of Science ®Google Scholar
• Suzuki S, Venkatesh D, Kanda H, et al. GLS2 Is a Tumor Suppressor and a Regulator of Ferroptosis in Hepatocellular Carcinoma. Cancer Res. 2022;82(18):3209–3222. doi:10.1158/0008-5472.CAN-21-3914
   PubMed Web of Science ®Google Scholar
• Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060–1072. doi:10.1016/j.cell.2012.03.042
   PubMed Web of Science ®Google Scholar
• Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22(4):266–282. doi:10.1038/s41580-020-00324-8
   PubMed Web of Science ®Google Scholar
• Luo P, Liu D, Zhang Q, et al. Celastrol induces ferroptosis in activated HSCs to ameliorate hepatic fibrosis via targeting peroxiredoxins and HO-1. Acta pharmaceutica Sinica B. 2022;12(5):2300–2314. doi:10.1016/j.apsb.2021.12.007
   PubMed Web of Science ®Google Scholar
• Li H, Deng C, Zhu N, Zhang C, Zeng Q, Qin L. An ultrasensitive GSH-specific fluorescent probe unveils celastrol-induced ccRCC ferroptosis. Bioorg Chem. 2023;134:106454. doi:10.1016/j.bioorg.2023.106454
   PubMedGoogle Scholar
• Stelzer G, Rosen N, Plaschkes I, et al. The genecards suite: from gene data mining to disease genome sequence analyses. Curr Protoc Bioinf. 2016;54:1.30.31–31.30.33. doi:10.1002/cpbi.5
   Google Scholar
• Kim S, Chen J, Cheng T, et al. PubChem 2023 update. Nucleic Acids Res. 2023;51(D1):D1373–d1380.
   PubMed Web of Science ®Google Scholar
• Wang X, Shen Y, Wang S, et al. PharmMapper 2017 update: a web server for potential drug target identification with a comprehensive target pharmacophore database. Nucleic Acids Res. 2017;45(W1):W356–w360. doi:10.1093/nar/gkx374
   PubMed Web of Science ®Google Scholar
• UniProt Consortium. UniProt: the universal protein knowledgebase in 2023. Nucleic Acids Res. 2023;51(D1):D523–d531. doi:10.1093/nar/gkac1052
   PubMed Web of Science ®Google Scholar
• Zhou N, Yuan X, Du Q, et al. FerrDb V2: update of the manually curated database of ferroptosis regulators and ferroptosis-disease associations. Nucleic Acids Res. 2023;51(D1):D571–d582.
   PubMedGoogle Scholar
• Szklarczyk D, Kirsch R, Koutrouli M, et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2023;51(D1):D638–d646. doi:10.1093/nar/gkac1000
   PubMed Web of Science ®Google Scholar
• Li X, Tang Q, Meng F, Du P, Chen W. INPUT: an intelligent network pharmacology platform unique for traditional Chinese medicine. Comput Struct Biotechnol J. 2022;20:1345–1351. doi:10.1016/j.csbj.2022.03.006
   PubMedGoogle Scholar
• Győrffy B. Discovery and ranking of the most robust prognostic biomarkers in serous ovarian cancer. Geroscience. 2023;45(3):1889–1898. doi:10.1007/s11357-023-00742-4
   PubMedGoogle Scholar
• Berman HM, Westbrook J, Feng Z, et al. The protein data bank. Nucleic Acids Res. 2000;28(1):235–242. doi:10.1093/nar/28.1.235
   PubMed Web of Science ®Google Scholar
• Mu X, Wang J, He H, et al. An oligomeric semiconducting nanozyme with ultrafast electron transfers alleviates acute brain injury. Sci Adv. 2021;7(46):eabk1210. doi:10.1126/sciadv.abk1210
   PubMed Web of Science ®Google Scholar
• Zhang S, Li Y, Sun S, et al. Single-atom nanozymes catalytically surpassing naturally occurring enzymes as sustained stitching for brain trauma. Nat Commun. 2022;13(1):4744. doi:10.1038/s41467-022-32411-z
   PubMedGoogle Scholar
• Gao R, Kalathur RKR, Coto-Llerena M, et al. YAP/TAZ and ATF4 drive resistance to Sorafenib in hepatocellular carcinoma by preventing ferroptosis. EMBO Mol Med. 2021;13(12):e14351. doi:10.15252/emmm.202114351
   PubMed Web of Science ®Google Scholar
• Park E, Chung SW. ROS-mediated autophagy increases intracellular iron levels and ferroptosis by ferritin and transferrin receptor regulation. Cell Death Dis. 2019;10(11):822. doi:10.1038/s41419-019-2064-5
   PubMed Web of Science ®Google Scholar
• Villanueva A. Hepatocellular Carcinoma. N Engl J Med. 2019;380(15):1450–1462. doi:10.1056/NEJMra1713263
   PubMed Web of Science ®Google Scholar
• Yu Y, Yan Y, Niu F, et al. Ferroptosis: a cell death connecting oxidative stress, inflammation and cardiovascular diseases. Cell Death Discov. 2021;7(1):193. doi:10.1038/s41420-021-00579-w
   PubMed Web of Science ®Google Scholar
• Mou Y, Wang J, Wu J, et al. Ferroptosis, a new form of cell death: opportunities and challenges in cancer. J Hematol Oncol. 2019;12(1):34. doi:10.1186/s13045-019-0720-y
   PubMed Web of Science ®Google Scholar
• Luo P, Zhang Q, Shen S, et al. Mechanistic engineering of celastrol liposomes induces ferroptosis and apoptosis by directly targeting VDAC2 in hepatocellular carcinoma. Asian J Pharm Sci. 2023;18(6):100874. doi:10.1016/j.ajps.2023.100874
   PubMedGoogle Scholar
• Liu M, Fan Y, Li D, et al. Ferroptosis inducer erastin sensitizes NSCLC cells to celastrol through activation of the ROS-mitochondrial fission-mitophagy axis. Mol Oncol. 2021;15(8):2084–2105. doi:10.1002/1878-0261.12936
   PubMed Web of Science ®Google Scholar
• Bian J, Ding Y, Wang S, et al. Celastrol confers ferroptosis resistance via AKT/GSK3β signaling in high-fat diet-induced cardiac injury. Free Radic Biol Med. 2023;200:36–46. doi:10.1016/j.freeradbiomed.2023.03.004
   PubMedGoogle Scholar
• Shen W, Li C, Liu Q, et al. Celastrol inhibits oligodendrocyte and neuron ferroptosis to promote spinal cord injury recovery. Phytomedicine. 2024;128:155380. doi:10.1016/j.phymed.2024.155380
   PubMedGoogle Scholar
• Pan M, Wang Z, Wang Y, et al. Celastrol alleviated acute kidney injury by inhibition of ferroptosis through Nrf2/GPX4 pathway. Biomed Pharmacothe. 2023;166:115333. doi:10.1016/j.biopha.2023.115333
   PubMedGoogle Scholar
• Liu JJ, Zhang X, Cai BL, et al. Ferroptosis inhibitors reduce celastrol toxicity and preserve its insulin sensitizing effects in insulin resistant HepG2 cells. J Integr Med. 2024;22:286–294. doi:10.1016/j.joim.2024.03.007
   PubMedGoogle Scholar
• Zhang X, Chen Y, Li X, et al. Carrier-free self-assembled nanomedicine based on celastrol and galactose for targeting therapy of hepatocellular carcinoma via inducing ferroptosis. Eur J Med Chem. 2024;267:116183. doi:10.1016/j.ejmech.2024.116183
   PubMedGoogle Scholar
• Liu J, Kang R, Tang D. Signaling pathways and defense mechanisms of ferroptosis. Febs j. 2022;289(22):7038–7050. doi:10.1111/febs.16059
   PubMed Web of Science ®Google Scholar
• Zhan X, Yan C, Chen Y, et al. Celastrol antagonizes high glucose-evoked podocyte injury, inflammation and insulin resistance by restoring the HO-1-mediated autophagy pathway. Mol Immunol. 2018;104:61–68. doi:10.1016/j.molimm.2018.10.021
   PubMed Web of Science ®Google Scholar
• Yu X, Tao W, Jiang F, Li C, Lin J, Liu C. Celastrol attenuates hypertension-induced inflammation and oxidative stress in vascular smooth muscle cells via induction of heme oxygenase-1. Am J Hypertens. 2010;23(8):895–903. doi:10.1038/ajh.2010.75
   PubMed Web of Science ®Google Scholar
• Yang X, Chen A, Liang Q, et al. Up-regulation of heme oxygenase-1 by celastrol alleviates oxidative stress and vascular calcification in chronic kidney disease. Free Radic Biol Med. 2021;172:530–540. doi:10.1016/j.freeradbiomed.2021.06.020
   PubMedGoogle Scholar
• Der Sarkissian S, Cailhier JF, Borie M, et al. Celastrol protects ischaemic myocardium through a heat shock response with up-regulation of haeme oxygenase-1. Br J Pharmacol. 2014;171(23):5265–5279. doi:10.1111/bph.12838
   PubMedGoogle Scholar
• Le TH. GSTM1 gene, diet, and kidney disease: implication for precision medicine?: Recent Advances in Hypertension. Hypertension. 2021;78(4):936–945. doi:10.1161/HYPERTENSIONAHA.121.16510
   PubMedGoogle Scholar
• Karimian M, Behjati M, Barati E, Ehteram T, Karimian A. CYP1A1 and GSTs common gene variations and presbycusis risk: a genetic association analysis and a bioinformatics approach. Environ Sci Pollut Res Int. 2020;27(34):42600–42610. doi:10.1007/s11356-020-10144-0
   PubMed Web of Science ®Google Scholar
• Liu W, Zhou Y, Duan W, et al. Glutathione peroxidase 4-dependent glutathione high-consumption drives acquired platinum chemoresistance in lung cancer-derived brain metastasis. Clin Translat Med. 2021;11(9):e517. doi:10.1002/ctm2.517
   PubMedGoogle Scholar